Literature DB >> 21059436

Relation of smoking status to serum levels of N-terminal pro-brain natriuretic peptide in middle-aged men without overt cardiovascular disease.

Toshiaki Otsuka1, Tomoyuki Kawada, Yoshihiko Seino, Chikao Ibuki, Masao Katsumata, Eitaro Kodani.   

Abstract

Cigarette smoking impairs arterial function and promotes atherosclerosis. However, whether smoking status is associated with cardiac overload has not yet been fully examined, particularly from an epidemiologic viewpoint. The present study examined the relation of smoking status to serum levels of N-terminal pro-brain natriuretic peptide (NT-pro-BNP), a marker of cardiac overload, in middle-aged men without overt cardiovascular disease. Serum NT-pro-BNP levels were measured in a work-site based population of 969 men (mean age 44 ± 6 years) who did not have any history or presence of cardiovascular disease. Smoking status was evaluated by self-reported questionnaire. Four hundred fifty-nine, 222, and 288 subjects were never, former, and current smokers, respectively. NT-pro-BNP levels were significantly higher in current smokers (21.7 ± 2.3 pg/ml) than in never smokers (17.9 ± 2.1 pg/ml, p <0.001). This significant difference was maintained even after adjusting for age, obesity, heart rate, hypertension, dyslipidemia, impaired fasting glucose/diabetes mellitus, left ventricular hypertrophy, estimated glomerular filtration rate, high-sensitivity C-reactive protein, alcohol consumption, and regular exercise. Current smokers had an increased odds ratio (3.04, 95% confidence interval 1.64 to 5.61, p <0.001) for elevated NT-pro-BNP (>54.5 pg/ml) compared to never smokers, even after adjusting for the studied variables. In contrast, former smokers did not show a significantly increased odds ratio for elevated NT-pro-BNP. NT-pro-BNP levels showed a weak, but significant negative correlation with duration of smoking cessation (partial r = -0.15, p = 0.034) in former smokers. In conclusion, these results suggest that cigarette smoking increases cardiac overload, whereas smoking cessation ameliorates these conditions.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21059436     DOI: 10.1016/j.amjcard.2010.06.075

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  11 in total

1.  Does the relationship between natriuretic hormones and diastolic function differ by race?

Authors:  Gaston K Kapuku; Harry C Davis; Patrick Thomas; James Januzzi; Gregory A Harshfield
Journal:  Am J Med Sci       Date:  2012-08       Impact factor: 2.378

2.  Expanding the role of cardiac biomarkers--natriuretic peptides and troponins--further in pre-Stage A.

Authors:  Yoshihiko Seino; Toshiaki Otsuka
Journal:  Hypertens Res       Date:  2014-09-25       Impact factor: 3.872

3.  Plasma B-type natriuretic peptide is a useful tool for assessing coronary heart disease risk in a Japanese general population.

Authors:  Takuya Hasegawa; Masanori Asakura; Kazuo Eguchi; Hiroshi Asanuma; Takahiro Ohara; Hideaki Kanzaki; Kazuhiko Hashimura; Hitonobu Tomoike; Jiyoong Kim; Masafumi Kitakaze
Journal:  Hypertens Res       Date:  2014-08-14       Impact factor: 3.872

4.  Cigarette Smoking and Incident Heart Failure: Insights From the Jackson Heart Study.

Authors:  Daisuke Kamimura; Loretta R Cain; Robert J Mentz; Wendy B White; Michael J Blaha; Andrew P DeFilippis; Ervin R Fox; Carlos J Rodriguez; Rachel J Keith; Emelia J Benjamin; Javed Butler; Aruni Bhatnagar; Rose M Robertson; Michael D Winniford; Adolfo Correa; Michael E Hall
Journal:  Circulation       Date:  2018-04-16       Impact factor: 29.690

5.  Association of menopause age and N-terminal pro brain natriuretic peptide: the Multi-Ethnic Study of Atherosclerosis.

Authors:  Imo A Ebong; Karol E Watson; David C Goff; David A Bluemke; Preethi Srikanthan; Tamara Horwich; Alain G Bertoni
Journal:  Menopause       Date:  2015-05       Impact factor: 2.953

Review 6.  Cardiovascular injury induced by tobacco products: assessment of risk factors and biomarkers of harm. A Tobacco Centers of Regulatory Science compilation.

Authors:  Daniel J Conklin; Suzaynn Schick; Michael J Blaha; Alex Carll; Andrew DeFilippis; Peter Ganz; Michael E Hall; Naomi Hamburg; Tim O'Toole; Lindsay Reynolds; Sanjay Srivastava; Aruni Bhatnagar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-02-01       Impact factor: 4.733

7.  Influence of cigarette smoking on cardiac biomarkers: the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Wilson Nadruz; Alexandra Gonçalves; Brian Claggett; Gabriela Querejeta Roca; Amil M Shah; Susan Cheng; Gerardo Heiss; Christie M Ballantyne; Scott D Solomon
Journal:  Eur J Heart Fail       Date:  2016-03-30       Impact factor: 15.534

8.  Elevated N-terminal pro-brain natriuretic peptide is associated with mortality in tobacco smokers independent of airflow obstruction.

Authors:  Jason A Stamm; Elizabeth A Belloli; Yingze Zhang; Jessica Bon; Frank C Sciurba; Mark T Gladwin
Journal:  PLoS One       Date:  2011-11-07       Impact factor: 3.240

9.  Hazardous alcohol consumption is associated with increased levels of B-type natriuretic peptide: evidence from two population-based studies.

Authors:  David A Leon; Vladimir M Shkolnikov; Svetlana Borinskaya; Juan-Pablo Casas; Alun Evans; Artyom Gil; Frank Kee; Nikolay Kiryanov; Martin McKee; Mark G O'Doherty; George B Ploubidis; Olga Polikina; Maxim Vassiliev; Stefan Blankenberg; Hugh Watkins
Journal:  Eur J Epidemiol       Date:  2013-05-05       Impact factor: 8.082

10.  Impact of Smoking Status on Growth Differentiation Factor 15 and Mortality in Patients With Suspected or Known Coronary Artery Disease: The ANOX Study.

Authors:  Hiromichi Wada; Masahiro Suzuki; Morihiro Matsuda; Yoichi Ajiro; Tsuyoshi Shinozaki; Satoru Sakagami; Kazuya Yonezawa; Masatoshi Shimizu; Junichi Funada; Takashi Takenaka; Yukiko Morita; Toshihiro Nakamura; Kazuteru Fujimoto; Hiromi Matsubara; Toru Kato; Takashi Unoki; Daisuke Takagi; Kyohma Wada; Miyaka Wada; Moritake Iguchi; Nobutoyo Masunaga; Mitsuru Ishii; Hajime Yamakage; Toru Kusakabe; Akihiro Yasoda; Akira Shimatsu; Kazuhiko Kotani; Noriko Satoh-Asahara; Mitsuru Abe; Masaharu Akao; Koji Hasegawa
Journal:  J Am Heart Assoc       Date:  2020-11-10       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.